Zobrazeno 1 - 10
of 142
pro vyhledávání: '"Kamran Badizadegan"'
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 597-613 (2024)
Background Despite multiple revisions of targets and timelines in polio eradication plans since 1988, including changes in supplemental immunization activities (SIAs) that increase immunity above routine immunization (RI) coverage, poliovirus transmi
Externí odkaz:
https://doaj.org/article/56006adf942c4ff9b9cb8d84cf41bf68
Autor:
Dominika A. Kalkowska, Kamran Badizadegan, Janell A. Routh, Cara C. Burns, Eli S. Rosenberg, I. Ravi Brenner, Jane R. Zucker, Marisa Langdon-Embry, Kimberly M. Thompson
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 186-195 (2024)
ABSTRACTBackground New York State (NYS) reported a polio case (June 2022) and outbreak of imported type 2 circulating vaccine-derived poliovirus (cVDPV2) (last positive wastewater detection in February 2023), for which uncertainty remains about poten
Externí odkaz:
https://doaj.org/article/31f2494c0ccf4136a5b7953143bd9224
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 813-825 (2023)
Background Achieving polio eradication requires ensuring the delivery of sufficient supplies of the right vaccines to the right places at the right times. Despite large global markets, decades of use, and large quantity purchases of polio vaccines by
Externí odkaz:
https://doaj.org/article/5161c7c4e8764371802a62965e8dc11a
Publikováno v:
Pathogens, Vol 13, Iss 6, p 435 (2024)
Continued investment in the development and application of mathematical models of poliovirus transmission, economics, and risks leads to their use in support of polio endgame strategy development and risk management policies. This study complements a
Externí odkaz:
https://doaj.org/article/a15a096dee6f44f2a263ed29f043d378
Autor:
Steven GF Wassilak, Dominika A Kalkowska, Concepcion F Estivariz, Eric Wiesen, Kimberly M Thompson, Cara C Burns, Kamran Badizadegan
Publikováno v:
Gates Open Research, Vol 7 (2023)
Background: The polio eradication endgame continues to increase in complexity. With polio cases caused by wild poliovirus type 1 and circulating vaccine-derived polioviruses of all three types (1, 2 and 3) reported in 2022, the number, formulation, a
Externí odkaz:
https://doaj.org/article/09d2a22264314e5abba8bb85eb389cb4
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
IntroductionDetection of poliovirus transmission and ongoing oral poliovirus vaccine (OPV) use continue to delay poliomyelitis eradication. In 2016, the Global Polio Eradication Initiative (GPEI) coordinated global cessation of type 2 OPV (OPV2) for
Externí odkaz:
https://doaj.org/article/6883d679fccd4a15beeefb383e82fdbf
Publikováno v:
Gates Open Research, Vol 6 (2022)
Background: Investments made by countries and donors to support polio eradication and the Global Polio Eradication Initiative (GPEI) over the past 35 years provided financial support for significant health interventions beyond the prevention of polio
Externí odkaz:
https://doaj.org/article/5a35a258a0f341098c342694abba73b8
Publikováno v:
BMC Health Services Research, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background Healthcare systems implement change at different rates because of differences in incentives, organizational processes, key influencers, and management styles. A comparable set of forces may play out at the national and internation
Externí odkaz:
https://doaj.org/article/ebc6cccc46e14e63ae0fedee6a78a860
Publikováno v:
Risk Anal
Since 2013, wild poliovirus (WPV) transmission occurred only for type 1 (WPV1). Following several years of increasing reported incidence (2017-2019) and programmatic disruptions caused by COVID-19 (early 2020), Pakistan and Afghanistan performed a la
Publikováno v:
Expert Rev Vaccines
BACKGROUND: Multiple vaccine options are available for polio prevention and risk management. Integrated global risk, economic, and poliovirus transmission modeling provides a tool to explore the dynamics of ending all use of one or more poliovirus va